Could a common diabetes drug stop oral cancer before it starts?
NCT ID NCT05237960
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 31 times
Summary
This study tests whether metformin, a common diabetes drug, can prevent oral cancer in 34 people with precancerous white or red patches in the mouth. Participants take metformin to see if it can reverse or stop these patches from turning into cancer. The goal is to find a safe, low-cost way to stop oral cancer before it develops.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHROPLAKIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
British Columbia Cancer Agency
Vancouver, British Columbia, V5Z 4E6, Canada
-
Dalhousie University
Halifax, Nova Scotia, B3H 4R2, Canada
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Louisiana State University
Lafayette, Louisiana, 70503, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
NYU College of Dentistry
New York, New York, 10010, United States
-
UC San Diego Medical Center - Hillcrest
San Diego, California, 92103, United States
-
University of Arizona Cancer Center-North Campus
Tucson, Arizona, 85719, United States
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109, United States
-
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.